ReviewDigestive diseases and sciences2026
Unravelling the Links Between Gastroesophageal Reflux and Lung Disease: New Insights.
Review in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Esophageal peristalsis in health and disease: mechanistic insights.Physiological reviews · 2026Review
- Gastroesophageal reflux disease predicts 6-month readmission in acute exacerbation of chronic obstructive pulmonary disease: development and validation of a nomogram.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastroesophageal reflux disease (GERD) is a prevalent comorbidity of chronic respiratory diseases including idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease, asthma, chronic obstructive pulmonary disease (COPD) and refractory chronic cough. Prevalence of symptoms of reflux and/ or refractory respiratory symptoms, along with concerns that refluxed gastric contents into the esophagus may micro-aspirate into the lungs causing injury and potentially accelerate disease progression, have resulted in high usage of empirical anti-reflux treatments. However, empirical treatment of reflux (medical or mechanical) is frequently ineffective without obvious explanation for the lack of respiratory improvement. This review provides novel and updated understanding of the pathophysiological mechanisms that link upper gut dysfunction, reflux (both distal and proximal), lung structure, lung mechanics and breathing patterns, including the potential role of the vagally mediated esophageal-bronchial reflex and the bi-directional nature of these interactions in individual respiratory diseases. We also highlight the need for a consensus between gastrointestinal and respiratory communities and propose a framework for diagnosing and managing GERD in respiratory disease.
Indexed as
Identifiers
41986862What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.